(HealthDay)—For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative prognostic marker, according to a study published online Sept. 15 in Clinical Cancer Research.
Sep 16, 2020
0
5
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the ...
Sep 15, 2020
0
9
Health products, like detox teas and mood-boosting waters, rely on a lack of neuroscientific knowledge to make their claims. Some of these claims are unsubstantiated, while others are completely made up.
Sep 7, 2020
0
5
A recent finding by researchers at the BC Cancer Research Institute and the University of British Columbia (UBC) may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovarian cancer.
Aug 27, 2020
0
4
A new study has identified a key gene in aggressive endometrial cancer, which could lead to a targeted therapeutic strategy to improve survival rates.
Aug 18, 2020
0
139
A tumor test could help to identify ovarian cancer patients with predicted poor survival, and down the track inform new therapeutical approaches, the results of a major international collaboration have shown.
Aug 17, 2020
0
194
Because cancer is easier to successfully treat when it's caught early, a major goal in cancer research is to develop new ways to find tumors at early stages, before they start to spread. One approach that's being studied ...
Aug 13, 2020
0
52
COVID-19 has ignited a worldwide conversation about inequality. The question is whether we just want to talk about inequity or make the changes to produce more fair outcomes.
Jul 20, 2020
0
0
(HealthDay)—African-American (AFR) men with prostate cancer have distinct genomic alterations from European-American (EUR) men, according to a study published online July 10 in Clinical Cancer Research.
Jul 14, 2020
0
1
Indiana University School of Medicine researchers Milan Radovich, Ph.D., and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's ...
Jul 9, 2020
0
3
